Torrent Pharmaceuticals Limited has announced the divestment of its entire stake in its associate company, UNM Foundation (a Section 8 Company). A total of 50,000 Equity Shares were sold to the Holding Company, Torrent Investments Limited, for a total consideration of ₹ 5,00,000/-. The transaction, which was completed on March 30, 2026, is classified as a related party transaction but was executed on an ‘arm’s length’ basis.
Disclosure of Divestment in Associate Company
Torrent Pharmaceuticals Limited has informed the exchanges regarding the sale of its entire holding in UNM Foundation, which is registered as a Section 8 Company and classified as an Associate Company. The disclosure was made pursuant to regulatory requirements governing material transactions.
Transaction Details
The transaction involved the disposal of 50,000 Equity Shares of UNM Foundation, each having a face value of ₹ 10/-. The total consideration received for this sale amounted to ₹ 5,00,000/-. The sale was concluded on March 30, 2026, at 19:40 pm.
Counterparty and Nature of Transaction
The buyer in this transaction was Torrent Investments Limited, which serves as both the Holding Company and Promoter of Torrent Pharmaceuticals Limited. Given the relationship, the company confirmed that this constitutes a related party transaction, and it was ensured that the terms and conditions were executed on an “arm’s length” basis.
Impact and Status
Since UNM Foundation is a Section 8 company, it contributes no revenue or turnover to Torrent Pharma’s financial results. The transfer of ownership was completed immediately upon entering the transaction details, as no formal sale agreement was required since the sale was made internally to the Holding Company. The disposal of the shares has been marked as Completed.
Source: BSE
